Kentucky Senate bill in Session 26RS.
Status: vetoed. Latest action: April 14, 2026.
AN ACT relating to ibogaine research in the Commonwealth.
Create new sections of KRS Chapter 218A to define terms; establish the ibogaine research and intellectual property fund to be administered by the Department of Agriculture for the purpose of allowing the department to enter a public-private partnership with a drug developer to conduct a clinical drug development trial or trials related to the use of ibogaine for the treatment of opioid use disorder, co-occurring substance use disorder, or any other neurological or mental health condition for which ibogaine demonstrates efficacy; establish requirements for the department related to how it contracts with a drug developer related to ibogaine research and intellectual property; appropriate $21 million from the opioid abatement trust fund to the ibogaine research and intellectual property development fund in fiscal year 2026-2027 and in fiscal year 2027-2028; APPROPRIATION; EMERGENCY.
| Date | Event | Detail |
|---|---|---|
| 2026-01-13 | Introduced | Bill introduced |
| 2026-04-14 | Status | vetoed |
| 2026-04-14 | Latest Action | 04/14/26: delivered to Secretary of State (Acts Ch. 158) |